The goals of the human mast cell and tissue acquisition Core B are focused and straightforward: to provide key services that will be used by all three Projects. Core B will provide well-defined materials to each of these projects to ensure coordinated methods of approach, and will be available to troubleshoot if problems arise. Located at the Northwestern University Feinberg School of Medicine under the leadership and supervision of Dr. Bruce Bochner, Core B will procure, catalog, store and ship de-identified biopsy samples from subjects with chronic rhinosinusitis, eosinophilic gastrointestinal disorders and atopic dermatitis in collaboration with physicians and scientists located at Northwestern for use primarily by Project 3. A second important task for Core B is to generate enriched mature human mast cells derived from tissues such as discarded human skin, as well as samples of human large intestine and lung resection specimens from the Northwestern Memorial Hospital for use in in vitro experiments. The third focus of Core B is to assist with and directly generate ?humanized? mast cell mice employing a method by which CD34+ human cells are transplanted into the triple transgenic NSG-SGM3 (NSGS) mice expressing human IL-3, GM-CSF and SCF. Finally, the fourth responsibility of Core B is to maintain important human and mouse mast cell lines, and to generate culture- derived mouse mast cells from bone marrow of mice expressing human Siglecs and from the bone marrow of the transplanted NSGS mice to generate culture-derived human mast cells, the latter two for use primarily by Projects 1 and 2. In short, Core B will provide an efficient, standardized and centralized source for mast cells, humanized mast cell mice, and human tissue specimens. The experience and expertise in isolating and generating mast cells will be critical to the success of Project 1 and Project 2, while the availability of de- identified biopsies and discarded surgical tissues from well-characterized cohorts of patients and controls are essential to the aims of Project 3.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program--Cooperative Agreements (U19)
Project #
5U19AI136443-03
Application #
9852964
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2020-02-01
Budget End
2021-01-31
Support Year
3
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Type
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Legrand, Fanny; Cao, Yun; Wechsler, Joshua et al. (2018) Siglec-8 in eosinophilic disorders: receptor expression and targeting using chimeric antibodies. J Allergy Clin Immunol :
Khoury, Paneez; Bochner, Bruce S (2018) Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options. J Allergy Clin Immunol Pract 6:1446-1453
Bochner, Bruce S (2018) The eosinophil: For better or worse, in sickness and in health. Ann Allergy Asthma Immunol 121:150-155
Gonzalez-Gil, Anabel; Porell, Ryan N; Fernandes, Steve M et al. (2018) Sialylated keratan sulfate proteoglycans are Siglec-8 ligands in human airways. Glycobiology 28:786-801
Khoury, Paneez; Akuthota, Praveen; Ackerman, Steven J et al. (2018) Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD). J Leukoc Biol 104:69-83
Bolden, Jessica E; Lucas, Erin C; Zhou, Geyu et al. (2018) Identification of a Siglec-F+ granulocyte-macrophage progenitor. J Leukoc Biol 104:123-133
Johansson, Mats W; Kelly, Elizabeth A; Nguyen, Christopher L et al. (2018) Characterization of Siglec-8 Expression on Lavage Cells after Segmental Lung Allergen Challenge. Int Arch Allergy Immunol 177:16-28
Wei, Yadong; Chhiba, Krishan D; Zhang, Fengrui et al. (2018) Mast Cell-Specific Expression of Human Siglec-8 in Conditional Knock-in Mice. Int J Mol Sci 20:
Yu, Huifeng; Gonzalez-Gil, Anabel; Wei, Yadong et al. (2017) Siglec-8 and Siglec-9 binding specificities and endogenous airway ligand distributions and properties. Glycobiology 27:657-668